The Ligand-Exchange Process of P–Hapical Phosphoranes
FULL PAPER
THF was freshly distilled from Na/benzophenone. Ethanol was dis-
tilled from magnesium. All other solvents were distilled from CaH2.
Phosphoranes 7[17c,20b] and 14[8c] were prepared according to pub-
lished procedures. Preparative thin layer chromatography was car-
yl]phenyl}propan-2-ol (10c): tBuLi (1.70 m in pentane, 3.60 mL,
6.12 mmol) was added to a solution of P–Hequatorial spirophos-
phorane 7 (1.00 mg, 1.94 mmol) in Et2O (20 mL) at –78 °C. After
removal of the cooling bath, the solution was stirred at room tem-
perature for 30 min. The solution was quenched with 1 m HCl
(20 mL), extracted with Et2O (3×50 mL), dried with anhydrous
MgSO4, and concentrated in vacuo. Separation and purification of
the residue was carried out by TLC (hexane/CH2Cl2 = 5:1) to give
a mixture (1.01 g, 92%) of 10cintra and 10cinter as a white powder.
ried out on plates of Merck silica gel 60 GF254
.
[TBPY-5-15]-1,1,1,3,3,3-Hexafluoro-2-{2-[1-methyl-3,3-bis(tri-
fluoromethyl)-1,3-dihydro-2,1λ5 -benzoxaphosphol-1-
yl]phenyl}propan-2-ol (10a): MeLi (1.14 m in Et2O, 5.67 mL,
6.46 mmol) was added to a solution of P–Hequatorial phosphorane
7 (460 mg, 0.891 mmol) in Et2O (10 mL) at –78 °C. After removal
of the cooling bath, the solution was stirred at room temperature
for 50 min. The solution was quenched with 1 m HCl (3 mL), ex-
tracted with Et2O (3×30 mL), dried with anhydrous MgSO4, and
concentrated in vacuo. Separation and purification of the residue
was carried out by TLC (hexane/CH2Cl2 = 5:1) to give 10a
(322 mg, 68%) and 5a (105 mg, 22%) as white solids. Recrystalli-
zation of 10a from hexane/CH2Cl2 gave crystals for X-ray analysis.
Recrystallization from hexane/CCl4 gave crystals of 10cintra. 10cintra
:
M.p. 108 °C. 1H NMR (CDCl3): δ = 8.58 (br. s, 1 H), 8.00–7.89
1
(m, 1 H), 7.80–7.48 (m, 7 H), 5.81 (d, JH,P = 273 Hz, 1 H), 1.30
3
(d, JH,P = 23.4 Hz, 9 H) ppm. 13C NMR (CDCl3): δ = 139.3 (d,
1
3
1JC,P = 139.7 Hz), 136.7 (d, JC,P = 132.4 Hz), 136.2 (d, JC,P
=
=
=
3
2
16.6 Hz), 134.6 (d, JC,P = 12.9 Hz), 134.0, 131.3 (d, JC,P
2
2
14.7 Hz), 130.6 (d, JC,P = 14.7 Hz), 129.5, 129.2 (d, JC,P
16.6 Hz), 129.0, 128.8 (d, 3JC,P = 3.9 Hz), 126.5 (d, JC,P = 16.6 Hz),
1
1
1
123.4 (q, JC,F = 286.8 Hz), 123.1 (q, JC,F = 290.4 Hz), 122.7 (q,
10a: M.p. 101 °C. H NMR (CDCl3): δ = 8.86 (br. s, 1 H), 8.10–
1
2
1
1JC,F = 288.6 Hz), 122.3 (q, JC,F = 288.6 Hz), 79.7 (sept, JC,F
=
7.90 (m, 1 H), 7.79 (br. s, 4 H), 7.55–7.20 (m, 3 H), 6.37 (dq, JH,P
2
1
= 276, 3JH,H = 3.9 Hz, 1 H), 2.44 (dd, 2JH,P = 14.7, 3JH,H = 3.9 Hz,
3 H) ppm. 13C NMR (CDCl3): δ = 136.7 (d, 2JC,P = 11.0 Hz), 134.8
31.3 Hz), 78.4 (sept, JC,F = 31.3 Hz), 43.8 (d, JC,P = 90.1 Hz),
15.1 ppm. 19F NMR (CDCl3): δ = –73.4 (q, JF,F = 9.5 Hz, 3 F), –
4
4
4
4
3
73.5 (q, JF,F = 9.5 Hz, 3 F), –74.6 (q, JF,F = 9.1 Hz, 3 F), –76.1
(br. s), 133.7 (d, JC,P = 3.7 Hz), 133.5 (br. s), 131.4 (d, JC,P
=
(q, JF,F = 10.7 Hz, 3 F) ppm. 31P NMR (CDCl3): δ = –14.7 ppm.
4
14.7 Hz), 131.1 (br. d, 2JC,P = 12.9 Hz), 129.8 (br. s), 129.6 (d, 1JC,P
= 123.2 Hz), 129.1 (br. d, JC,P = 14.7 Hz), 128.3 (d, JC,P
141.3 Hz), 128.2 (d, JC,P = 25.7 Hz), (d, JC,F = 286.8 Hz), 124.8
3
1
C22H19F12O2P (574.34): calcd. C 46.01, H 3.33; found C 45.85, H,
3.23. Recrystallization from hexane/EtOH gave crystals of 10cinter
(containing EtOH). An X-ray sample was recrystallized from hex-
ane/MeCN. 10cinter: M.p. 83–84 °C (containing EtOH). 1H NMR
([D6]acetone, without EtOH): δ = 8.77–8.72 (m, 1 H), 7.87–7.82
(m, 1 H), 7.75–7.63 (m, 4 H), 7.63–7.54 (m, 2 H), 7.48 (s, 1 H),
=
2
1
3
1
1
(d, JC,P = 14.7 Hz), 122.6 (q, JC,F = 284.8 Hz), 122.4 (q, JC,F
=
290.4 Hz), 122.2 (q, 1JC,F = 290.5 Hz), 79.0 (sept, 2JC,F = 35.0 Hz),
78.9 (sept, JC,F = 33.1 Hz), 22.4 (d, JC,P = 99.3 Hz) ppm. 19F
NMR (CDCl3): δ = –72.9 (br. s, 3 F), –76.3 (br. s, 3 F), –76.9 (br.
s, 3 F), –77.0 (br. s, 3 F) ppm. 31P NMR (CDCl3): δ = –51.9 ppm.
C19H13F12O2P (532.26): calcd. C 42.88, H 2.46; found C 42.75, H
2.37.
2
1
1
3
6.07 (d, JH,P = 293 Hz, 1 H), 1.17 (d, JH,P = 19.5 Hz, 9 H) ppm.
13C NMR ([D6]acetone, without EtOH): δ = 141.3 (d, JC,P
141.3 Hz), 139.0 (d, JC,P = 5.5 Hz), 137.1 (d, JC,P = 14.7 Hz),
136.1 (d, 3JC,P = 14.7 Hz), 135.1 (d, 1JC,P = 139.7 Hz), 133.9, 132.7
(d, 2JC,P = 3.6 Hz), 130.7, 130.1 (d, 2JC,P = 12.9 Hz), 128.6 (d, 3JC,P
=
1
4
2
[TBPY-5-15]-1,1,1,3,3,3-Hexafluoro-2-{2-[1-butyl-3,3-bis(trifluoro-
methyl)-1,3-dihydro-2,1λ5-benzoxaphosphol-1-yl]phenyl}propan-2-ol
(10b): nBuLi (1.62 m in hexane, 2.00 mL, 3.24 mmol) was added to
a solution of P–Hequatorial spirophosphorane 7 (500 mg,
0.969 mmol) in Et2O (10 mL) at –78 °C. After removal of the cool-
ing bath, the solution was stirred at room temperature for 60 min.
The solution was quenched with 1 m HCl (10 mL), extracted with
Et2O (3×30 mL), dried with anhydrous MgSO4, and concentrated
in vacuo. Separation and purification of the residue was carried
out by TLC (hexane/CH2Cl2 = 5:1) to give 10b (322 mg, 68%) and
5b (105 mg, 22%) as white solids. Recrystallization of 10b from
hexane/CH2Cl2 gave crystals suitable for X-ray analysis. 10b: M.p.
3
1
= 7.4 Hz), 125.9 (d, JC,P = 12.9 Hz), 125.2 (q, JC,F = 286.8 Hz),
1
1
124.7 (q, JC,F = 288.6 Hz), 124.6 (q, JC,F = 290.5 Hz), 122.3 (q,
1JC,F = 288.7 Hz), 81.0 (sept, JC,F = 29.5 Hz), 80.0 (sept, JC,F
=
2
2
29.4 Hz), 38.6 (d, JC,P = 97.5 Hz), 19.4 ppm. 19F NMR ([D6]ace-
1
4
9
tone, without EtOH): δ = –73.3 (qq, JF,F = 8.9, JF,F = 3.1 Hz, 3
4
4
F), –73.6 (q, JF,F = 9.5 Hz, 3 F), –74.3 (q, JF,F = 8.6 Hz, 3 F),
–75.5 (qq, JF,F = 9.2, JF,F = 2.8 Hz, 3 F) ppm. 31P NMR ([D6]-
acetone, without EtOH): δ = –40.1 ppm. C24H25F12O3P (620.41):
calcd. C 46.46, H 4.06 (containing EtOH); found C 46.26, H, 3.90.
4
9
[TBPY-5-12]-1-Methyl-3,3,3Ј,3Ј-tetrakis(trifluoromethyl)-1,1Ј-
spirobi[1,3-dihydro-2,1λ5-benzoxaphosphole] (6a): A solution of P–
Hapical phosphorane 10a (50 mg, 9.4×10–2 mmol) in THF (0.5 mL)
was heated at 40 °C for 1 h. The solution was concentrated in
vacuo. Purification of the residue was carried out by TLC (hexane/
CH2Cl2 = 2:1) to give 5a (Rf = 0.8, 23 mg, 46%) and 6a (Rf = 0.9,
1
119 °C. H NMR (CDCl3): δ = 9.13 (br. s, 1 H), 8.07–8.02 (m, 1
H), 7.89–7.85 (m, 1 H), 7.80–7.72 (m, 3 H), 7.45–7.41 (m, 1 H),
1
3
7.36–7.32 (m, 1 H), 6.16 (dd, JH,P = 273, JH,H = 5.9 Hz, 1 H),
3.21–3.06 (m, 1 H), 2.69–2.52 (m, 1 H), 1.65–1.46 (m, 1 H), 1.45–
3
1.36 (m, 2 H), 1.35–1.22 (m, 1 H), 0.88 (t, JH,H = 7.3 Hz, 3 H)
2
ppm. 13C NMR (CDCl3): δ = 136.6 (d, JC,P = 12.8 Hz), 136.1 (d,
1
26 mg, 52%) as white solids. 5a: M.p. 134 °C. H NMR (CDCl3):
3
3
1JC,P = 139.7 Hz), 134.7, 134.3 (d, JC,P = 14.7 Hz), 134.1 (d, JC,P
δ = 8.43–8.38 (m, 2 H), 7.79–7.69 (m, 6 H), 2.11 (d, 2JH,P = 16.6 Hz,
2
1
3
3 H) ppm. 13C NMR (CDCl3): δ = 136.8 (d, JC,P = 9.1 Hz), 136.1
= 14.7 Hz), 130.8 (d, JC,P = 16.5 Hz), 130.2, 129.8 (d, JC,P
139.7 Hz), 129.7, 129.1 (d, JC,P = 16.6 Hz), 127.0 (d, JC,P
=
=
2
3
2
4
2
(d, JC,P = 20.2 Hz), 133.7 (d, JC,P = 3.7 Hz), 131.4 (d, JC,P
=
1
1
1
3
12.9 Hz), 123.4 (d, JC,F = 290.4 Hz), 122.7 (q, JC,F = 286.8 Hz),
14.7 Hz), 130.6 (d, JC,P = 176.5 Hz), 124.8 (d, JC,P = 14.7 Hz),
122.5 (q, 1JC,F = 286.8 Hz), 122.3 (q, JC,F = 288.6 Hz), 78.9 (sept,
1
1
1
122.6 (q, JC,F = 285.0 Hz), 122.4 (q, JC,F = 288.6 Hz), 81.3 (sept,
2JC,F = 31.2 Hz), 78.6 (sept, JC,F = 31.2 Hz), 34.7 (d, JC,P
=
2
1
2JC,F = 31.2 Hz), 25.2 (d, JC,P = 125.0 Hz) ppm. 19F NMR
1
90.1 Hz), 27.7, 23.5 (d, JC,P = 23.9 Hz), 13.6 ppm. 19F NMR
2
(CDCl3): δ = –75.1 (q, 4JF,F = 9.5 Hz, 6 F), –75.4 (q, 4JF,F = 9.5 Hz,
6 F) ppm. 31P NMR (CDCl3): δ = –22.6 ppm. C19H11F12O2P
(530.24): calcd. C 43.04, H 2.09; found C 42.83, H 1.86. 6a: M.p.
(CDCl3): δ = –72.9 (br. s, 3 F), –76.3 (q, 4JF,F = 9.2 Hz, 3 F), –76.8
4
4
9
(q, JF,F = 8.2 Hz, 3 F), –77.0 (q, JF,F = 9.2, JF,F = 4.9 Hz, 3 F)
ppm. 31P NMR (CDCl3): δ = –34.4 ppm. C22H19F12O2P (574.34):
calcd. C 46.01, H 3.33; found C 46.09, H, 3.24.
1
2
127 °C. H NMR (CDCl3): δ = 7.80–7.31 (m, 8 H), 2.28 (d, JH,P
= 10.2 Hz, 3 H) ppm. 13C NMR (CDCl3): δ = 136.8 (d, JC,P
9.1 Hz), 136.1 (d, JC,P = 20.2 Hz), 133.8 (d, JC,P = 3.7 Hz), 132.3
(br. s), 132.0 (br. s), 131.4 (d, JC,P = 14.7 Hz), 130.3 (d, JC,P
=
[TBPY-5-15]-1,1,1,3,3,3-Hexafluoro-2-{2-[1-(1,1-dimethylethyl)-3,3-
bis(trifluoromethyl)-1,3-dihydro-2,1λ5-benzoxaphosphol-1-
=
Eur. J. Org. Chem. 2006, 218–234
© 2006 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
www.eurjoc.org
231